Cargando…
Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis
Crescentic glomerulonephritis is a devastating autoimmune disease that without early and properly treatment may rapidly progress to end-stage renal disease and death. Current immunosuppressive treatment provides limited efficacy and an important burden of adverse events. Epigenetic drugs are a sourc...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876310/ https://www.ncbi.nlm.nih.gov/pubmed/35215234 http://dx.doi.org/10.3390/ph15020121 |
_version_ | 1784658138625998848 |
---|---|
author | Tejedor-Santamaria, Lucia Morgado-Pascual, Jose Luis Marquez-Exposito, Laura Suarez-Alvarez, Beatriz Rodrigues-Diez, Raul R. Tejera-Muñoz, Antonio Marchant, Vanessa Mezzano, Sergio Lopez-Larrea, Carlos Sola, Anna Fernandez-Juarez, Gema Maria Ortiz, Alberto Rayego-Mateos, Sandra Ruiz-Ortega, Marta |
author_facet | Tejedor-Santamaria, Lucia Morgado-Pascual, Jose Luis Marquez-Exposito, Laura Suarez-Alvarez, Beatriz Rodrigues-Diez, Raul R. Tejera-Muñoz, Antonio Marchant, Vanessa Mezzano, Sergio Lopez-Larrea, Carlos Sola, Anna Fernandez-Juarez, Gema Maria Ortiz, Alberto Rayego-Mateos, Sandra Ruiz-Ortega, Marta |
author_sort | Tejedor-Santamaria, Lucia |
collection | PubMed |
description | Crescentic glomerulonephritis is a devastating autoimmune disease that without early and properly treatment may rapidly progress to end-stage renal disease and death. Current immunosuppressive treatment provides limited efficacy and an important burden of adverse events. Epigenetic drugs are a source of novel therapeutic tools. Among them, bromodomain and extraterminal domain (BET) inhibitors (iBETs) block the interaction between bromodomains and acetylated proteins, including histones and transcription factors. iBETs have demonstrated protective effects on malignancy, inflammatory disorders and experimental kidney disease. Recently, Gremlin-1 was proposed as a urinary biomarker of disease progression in human anti-neutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis. We have now evaluated whether iBETs could regulate Gremlin-1 in experimental anti-glomerular basement membrane nephritis induced by nephrotoxic serum (NTS) in mice, a model resembling human crescentic glomerulonephritis. In NTS-injected mice, the iBET JQ1 inhibited renal Gremlin-1 overexpression and diminished glomerular damage, restoring podocyte numbers. Chromatin immunoprecipitation assay demonstrated BRD4 enrichment of the Grem-1 gene promoter in injured kidneys, consistent with Gremlin-1 epigenetic regulation. Moreover, JQ1 blocked BRD4 binding and inhibited Grem-1 gene transcription. The beneficial effect of iBETs was also mediated by modulation of NOTCH pathway. JQ1 inhibited the gene expression of the NOTCH effectors Hes-1 and Hey-1 in NTS-injured kidneys. Our results further support the role for epigenetic drugs, such as iBETs, in the treatment of rapidly progressive crescentic glomerulonephritis. |
format | Online Article Text |
id | pubmed-8876310 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-88763102022-02-26 Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis Tejedor-Santamaria, Lucia Morgado-Pascual, Jose Luis Marquez-Exposito, Laura Suarez-Alvarez, Beatriz Rodrigues-Diez, Raul R. Tejera-Muñoz, Antonio Marchant, Vanessa Mezzano, Sergio Lopez-Larrea, Carlos Sola, Anna Fernandez-Juarez, Gema Maria Ortiz, Alberto Rayego-Mateos, Sandra Ruiz-Ortega, Marta Pharmaceuticals (Basel) Article Crescentic glomerulonephritis is a devastating autoimmune disease that without early and properly treatment may rapidly progress to end-stage renal disease and death. Current immunosuppressive treatment provides limited efficacy and an important burden of adverse events. Epigenetic drugs are a source of novel therapeutic tools. Among them, bromodomain and extraterminal domain (BET) inhibitors (iBETs) block the interaction between bromodomains and acetylated proteins, including histones and transcription factors. iBETs have demonstrated protective effects on malignancy, inflammatory disorders and experimental kidney disease. Recently, Gremlin-1 was proposed as a urinary biomarker of disease progression in human anti-neutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis. We have now evaluated whether iBETs could regulate Gremlin-1 in experimental anti-glomerular basement membrane nephritis induced by nephrotoxic serum (NTS) in mice, a model resembling human crescentic glomerulonephritis. In NTS-injected mice, the iBET JQ1 inhibited renal Gremlin-1 overexpression and diminished glomerular damage, restoring podocyte numbers. Chromatin immunoprecipitation assay demonstrated BRD4 enrichment of the Grem-1 gene promoter in injured kidneys, consistent with Gremlin-1 epigenetic regulation. Moreover, JQ1 blocked BRD4 binding and inhibited Grem-1 gene transcription. The beneficial effect of iBETs was also mediated by modulation of NOTCH pathway. JQ1 inhibited the gene expression of the NOTCH effectors Hes-1 and Hey-1 in NTS-injured kidneys. Our results further support the role for epigenetic drugs, such as iBETs, in the treatment of rapidly progressive crescentic glomerulonephritis. MDPI 2022-01-20 /pmc/articles/PMC8876310/ /pubmed/35215234 http://dx.doi.org/10.3390/ph15020121 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Tejedor-Santamaria, Lucia Morgado-Pascual, Jose Luis Marquez-Exposito, Laura Suarez-Alvarez, Beatriz Rodrigues-Diez, Raul R. Tejera-Muñoz, Antonio Marchant, Vanessa Mezzano, Sergio Lopez-Larrea, Carlos Sola, Anna Fernandez-Juarez, Gema Maria Ortiz, Alberto Rayego-Mateos, Sandra Ruiz-Ortega, Marta Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title | Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title_full | Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title_fullStr | Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title_full_unstemmed | Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title_short | Epigenetic Modulation of Gremlin-1/NOTCH Pathway in Experimental Crescentic Immune-Mediated Glomerulonephritis |
title_sort | epigenetic modulation of gremlin-1/notch pathway in experimental crescentic immune-mediated glomerulonephritis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876310/ https://www.ncbi.nlm.nih.gov/pubmed/35215234 http://dx.doi.org/10.3390/ph15020121 |
work_keys_str_mv | AT tejedorsantamarialucia epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT morgadopascualjoseluis epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT marquezexpositolaura epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT suarezalvarezbeatriz epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT rodriguesdiezraulr epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT tejeramunozantonio epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT marchantvanessa epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT mezzanosergio epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT lopezlarreacarlos epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT solaanna epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT fernandezjuarezgemamaria epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT ortizalberto epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT rayegomateossandra epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis AT ruizortegamarta epigeneticmodulationofgremlin1notchpathwayinexperimentalcrescenticimmunemediatedglomerulonephritis |